Obstetrics, gynecology, andrology, sexual and reproductive health

HIV/AIDS

PubMed Free Full Text

Antiretroviral therapy: adverse events, complications

 

Brazil

• Medicine
  • The Brazilian experience of implementing the active pharmacovigilance of dolutegravir [2019]

• Therapeutics and Clinical Risk Management
  • HIV-associated lipodystrophy: a review from a Brazilian perspective [2014]

China

• Frontiers in Pharmacology
  • Six-Year Immunologic Recovery and Virological Suppression of HIV Patients on LPV/r-Based Second-Line Antiretroviral Treatment: A Multi-Center Real-World Cohort Study in China [2019]

Eswatini

• AIDS Research and Therapy
  • An evaluation of postmarketing reports of hyperglycaemia associated with dolutegravir for treatment of HIV in Eswatini [2022]

Ethiopia

• BMC Infectious Diseases
  • Prevalence of hepatotoxicity among HIV-infected patients in Ethiopia: a systematic review and meta-analysis [2022]

Indonesia

• Asian Pacific Journal of Allergy and Immunology
  • Incidence and predictors of nevirapine and efavirenz-associated rash among Indonesian HIV patients [2022]

International

• AIDS Research and Treatment
  • What is polypharmacy in people living with HIV/AIDS? A systematic review [2022]

South Africa

• South African Journal of Communication Disorders
  • Dysphagia and pill swallowing in HIV/AIDS in South Africa: Results of a scoping review [2023]

Sub-Saharan Africa

• Infectious Diseases of Poverty
  • Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new “test and treat” policy of the World Health Organization? [2017]

Sweden

• PLoS ONE
  • Longitudinal trends and determinants of patient-reported side effects on ART–a Swedish national registry study [2020]

United Kingdom

• National Institute for Health and Care Excellence
  • Deep dermal injection of non-absorbable gel polymer for HIV-related lipoatrophy [2013]

United States

• New York State Department of Health AIDS Institute
  • Laboratory Monitoring for Adverse Effects of ART [2021]

WHO

• World Health Organization
  • Surveillance of antiretroviral toxicity: global HIV, hepatitis and STIs programme: what's new in person-centred HIV patient and antiretroviral drug toxicity monitoring: technical brief [2020]
  • Monitoring toxicity of antiretrovirals

{Related topics}

• Guidelines
  • Antiretroviral therapy